Sociedad Americana de Hirudoterapia

Early venous congestion after DIEP flap breast reconstruction: case report of a successful management

Baccarani A, Starnoni M, Pappalardo M, Lattanzi M, Blessent CGF, De Maria F, De Santis G (2022) · Acta Biomedica · n=1

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Breast Reconstruction Flap Salvage
Sample size of this trial compared with other Breast Reconstruction Flap Salvage trialsRajaram R 202428Maetz B 20122Baccarani A 20221Freeman M 20151Moffat AD 20151Torresetti M 20241
This trial (highlighted) by sample size alongside other indexed Breast Reconstruction Flap Salvage trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-patient case report of DIEP flap breast-reconstruction venous congestion 9 hours postoperatively, managed with combined surgical pedicle revision, intensive ICU heparin infusion, and 2 days of medicinal-leech therapy (Università di Modena e Reggio Emilia, Italy)
Sample size (n)
1
Intervention
Combined microsurgical pedicle revision + IV heparin infusion + medicinal leech therapy for 2 days for DIEP venous congestion
Comparator
Not applicable — single case; comparator is broader DIEP-failure literature
Primary endpoint
Flap salvage and resolution of venous congestion
Primary result
Complete resolution of flap venous congestion; patient discharged with viable DIEP flap reconstruction; case illustrates multidisciplinary protocol with ICU-level monitoring, heparin, and leech therapy as concurrent interventions; emphasizes 6-8 hour irreversible-damage window for venous congestion recognition
Follow-up duration
Acute postoperative through discharge

Key Findings

  • Successful DIEP flap salvage with combined surgery + heparin + 2-day leech therapy
  • Authors emphasize 6-8 hour irreversible-damage window for venous congestion
  • Demonstrates multidisciplinary ICU-level care including leech application
  • Adds Italian academic-center experience to the published DIEP leech-salvage literature
  • Consistent with broader Rajaram 2024 systematic review pooled estimates

Limitations

  • Single case (n=1) — cannot generalize
  • Combined intervention prevents isolation of leech contribution
  • Limited follow-up duration
  • No standardized outcome measure
  • Single-center experience

Clinical Implications

Baccarani 2022 illustrates real-world DIEP flap salvage protocols in an Italian academic plastic surgery program. For US clinicians under K040187, the case reinforces the value of rapid recognition (<6-8 hours), multidisciplinary involvement (microsurgery + ICU + pharmacy), and combined-modality therapy (surgical pedicle revision + heparin + leech therapy) for DIEP venous congestion. Consistent with Rajaram 2024 SR pooled outcomes.

Related Trials

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.